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Background: It is presently unknown if stents used in the correction of artery stenosis are fully 
hemocompatible or if their implantation causes alterations at the level of the plasma membrane 
in red blood cells.
Methods: We addressed this important issue by measuring the passive electrical properties 
of the erythrocyte membrane before and after stent insertion by means of dielectric relaxation 
spectroscopy in the radiowave frequency range in a series of patients who were undergoing 
standard surgical treatment of arterial disease.
Results: Our findings provide evidence that full hemocompatibility of stents has not yet been 
reached, and that there are some measurable alterations in the passive electrical behavior of the 
red blood cell membrane induced by the presence of the stent.
Conclusion: It is possible that these changes do not have any physiological significance and 
simply reflect the intrinsic variability of biological samples. However, caution is urged, and the 
technique we describe here should be considered when investigating the hemocompatibility of 
a medical device at a cell membrane level.
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Introduction
A biomaterial can only be considered truly biocompatible when it satisfies two 
  conditions. First, the physicochemical properties of the biomaterial should remain 
unchanged over time, so that it can exert its function without alteration. Second, the 
biomaterial should not cause any change in the biological system with which it comes 
in contact, ie, it must do what it is supposed to do without provoking any unwanted 
modification in the host system. Therefore, the biomaterial must not only be completely 
inert, but must also not have any undesirable effects. These two requirements are 
often, at least partially, in conflict, meaning that a completely inert biomaterial may 
be ineffective at the target to which it is directed, in the same way as a particularly 
active biomaterial may induce unwanted reactions. The key is to find an appropriate 
compromise in the evaluation of cost-benefit, considering the advantages conferred 
by the biomaterial versus the possible, and in many cases unavoidable, alterations it 
may provoke in the host system.
Biomaterials have become very popular medical devices. There are several defini-
tions of biomaterials. In 1982, the National Institutes of Health determined that the 
word “biomaterial” means “any substance or any combination of substances different 
from drugs of a natural or synthetic origin, which could be used for any period of time 
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by itself or as a part of a system which handles, increases or 
replaces any kind of tissue, organ or function of the body”. 
It is certainly not easy, even keeping in mind the great vari-
ability of materials used in different applications, to find a 
parameter which verifies the biocompatibility of a biomaterial 
in an objective and measurable way.1,2
For devices which come into contact with blood, such 
as those used in antithrombogenic implants, hemocompat-
ibility is necessary, and lack of it could lead to many clinical 
complications, including chronic inflammation or cytotoxic 
effects.
A significant proportion of cardiovascular disease 
is caused by clogging of the arteries due to buildup of 
  cholesterol. Stenting is one of the most common proce-
dures used to treat stenosis, and many devices for arterial 
intervention have been tested during the last 20 years. 
Multidisciplinary efforts have been put into stent research 
and, as a result, new designs and different materials and 
coatings have been proposed to improve the performance 
of these prostheses. Among these, polymeric-coated stents, 
heparin-coated stents, drug-eluting stents, and others warrant 
mention.3 However, medical complications, including stent 
thrombosis, cholesterol accumulation, restenosis, inflamma-
tion, and hyperplasia are not infrequent.
It is unknown if, in addition to these unwanted macro-
scopic reactions, other alterations could be present at the 
level of the cell membrane. Therefore, it is fundamental to 
understand the dynamic processes that regulate interaction 
between the foreign material and the host system at the 
molecular level. Because the stent is placed in direct contact 
with a layer of erythrocytes and blood platelets, and there 
is no barrier between them and the material itself, the best 
strategy for investigating the cytotoxicity and biocompat-
ibility of these devices is to examine parameters that describe 
the electrical properties of the cell membrane. Among these, 
two parameters, both of an electrical nature, have relevance 
in the characterization of both the structure and function of 
the plasma membrane. These are membrane permittivity (εs) 
and membrane conductivity (σs).4 The former is related to the 
distribution of charges and/or polar groups across the mem-
brane lipid bilayer, and the latter is a measure of the overall 
ionic transport occurring across the cell membrane through 
ion channels and pores. These parameters involve some of 
the most important characteristics of the cell membrane, as 
far as their electrical behavior is concerned.
Consequently, knowledge about these parameters 
offers the opportunity to determine if an alteration in the 
cell membrane has occurred, induced by interaction with 
the   biomaterial with which it comes in contact. In other 
words, the membrane permittivity (εs) and the membrane 
conductivity (σs) can be used as parameters to judge the 
biocompatibility of stents at a microscopic level. The absence 
of changes in εs and σs after prosthesis insertion is a neces-
sary prerequisite so that the material does not provoke any 
alteration in red blood cells, at least as far as their electrical 
properties are concerned.
It should be borne in mind that the cell membrane sepa-
rates media of different electrical properties (the extracellular 
solution and the cytosol) and, consequently, under the influ-
ence of an external electric field, charge polarization takes 
place at the interface between these two media. In particular, 
at frequencies of 1–100 mHz, a cell suspension undergoes a 
marked dielectric relaxation effect due to interfacial polar-
ization, known in the colloidal community as β dispersion.5 
Because of this effect, using an appropriate dielectric cell 
model, it is possible to determine the two aforementioned 
electrical parameters, ie, membrane permittivity (εs) and 
membrane conductivity (σs) and then characterize the elec-
trical behavior of the cell membrane and ascertain if it is a 
site of possible alteration.
The dielectric properties of biological cell suspensions 
have been extensively studied since the beginning of the 20th 
century,6 and since then a variety of different biological cells 
have been investigated.5,7–9
In the present work, we measured the electrical parameters 
of red blood cell membranes, ie, permittivity (εs), electrical 
conductivity (σs), and conductivity (σp) of the cytosol in 
patients who had undergone correction of arterial stenosis 
by means of a metallic stent in order to ascertain the full 
biocompatibility of these devices.
In the past, we have observed that different kinds of stents 
could induce remarkable alteration in the passive electri-
cal behavior of erythrocytes, but our observation has been 
limited to a period of 30 days after surgery at the most.10–12 
Here we have extended those investigations, and followed 
the electrical parameters of the cell membrane for a much 
longer period of time of up to 8 months. Our results confirm 
once again that full hemocompatibility is not yet reached, 
at least on the basis of the definition given earlier, and that 
a word of caution is necessary.
Materials and methods
Materials
Data were collected from 14 patients who underwent standard 
surgical treatment for arterial disease using a stainless steel 
BioMatrix stent (Biosensors Interventional Technologies 
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Pte Ltd, Singapore). These devices offer a combination 
of an antirestenotic drug (a biodegradable polylactic acid 
  polymer) and a highly flexible material, and are widely used 
for arterial implantation. The stents were implanted according 
to the guidelines of the US Food and Drug Administration, 
the American Association for Vascular Surgery,13 and the 
Society for Vascular Surgery.14 All patients were numbered 
in consecutive order. Individuals who had had major surgery 
or a blood transfusion within the previous 6 months were 
excluded from the study.
Blood samples were obtained from the patients immedi-
ately before and after (within a period of time of 4 months 
and 8 months, respectively) insertion of the stent. The eryth-
rocytes were centrifuged at 1000 × g for 5 minutes. The 
supernatant and buffy coat were removed by aspiration. The 
cells were resuspended and washed in 10 mL of phosphate-
buffered saline (145 mM NaCl and 5 mM phosphate, pH 
7.32) three times. The hematocrit of the final erythrocyte 
suspension was measured and adjusted to a Φ of 0.20. This 
choice is a reasonable compromise between the need to have 
a high value of the volume fraction (Φ), in order to increase 
the dielectric effect, and to have a volume fraction not too 
high in order to reduce cell-cell interactions, as necessary 
for the dielectric model we used. Dielectric measurements 
were completed within 1–2 hours of the start of preparation 
of each sample.
The present study was carried out using erythrocytes 
isolated from whole blood and then dispersed in physi-
ological saline. It could be relevant to extend these dielectric 
measurements to platelet-rich plasma, rather than erythrocyte 
suspensions, given that blood platelets are central to the 
process of thrombosis.
Dielectric measurements
Measurements of the dielectric properties of the erythrocyte 
suspensions were carried out using commercially available 
Hewlett-Packard impedance analyzers, ie, model 4192A, 
in the frequency range from 1 kHz to 10 MHz, and model 
4291A, in the frequency range from 1 MHz to 2 GHz, together 
with a sample measuring cell consisting of a short section of 
a 3 mm electrode space coaxial cable connected by an APC7 
precision connector to the meter. The sample cell was kept at 
a temperature of 25.0°C ± 0.1°C in a temperature-controlled 
bath. Each run in the frequency window investigated was 
taken three times and the datum points are the average of 
these runs. The overall uncertainty of the measured permit-
tivity εs (ω) and the measured conductivity σs (ω) was 0.5% 
and 1%, respectively. In order to avoid further thermal shock, 
dielectric measurements were carried out using the same 
temperature (25°C) at which the samples were maintained 
during preparation.
Dielectric model
The dielectric relaxation data and, in particular, the dielectric 
dispersion occurring in the intermediate frequency range of 
the frequency window investigated, were analyzed within 
the usual heterogeneous system theory framework.4,5,15,16 
From a dielectric point of view, a biological cell suspension 
can be considered as a collection of ellipsoidal particles 
uniformly dispersed in a continuous aqueous phase.5 In the 
case of a red blood cell, each particle is represented by an 
oblate ellipsoid of semi axes, a0 and b0, of complex dielec-
tric constant εω εσ ωε *( )/ pp p i =+ 0, covered by a confocal 
shell of complex dielectric constant εω εσ ωε *( )/ ss s i =+ 0 
and thickness d, and immersed in an aqueous phase of 
complex dielectric constant εω εσ ωε *( )/ mm m i =+ 0. Here, 
i =− 1, ω is the angular frequency of the applied electric 
field, and ε0 = 8.96 10–12 F/m is the dielectric constant of 
free space.
Within this scheme, the cell membrane and the cytosol are 
characterized by three electrical parameters, ie, εs (membrane 
permittivity), σs (membrane conductivity), and εp (intracel-
lular permittivity). Dielectric spectra, recorded over a wide 
enough frequency interval, allow these electrical parameters 
to be evaluated appropriately, offering the opportunity to 
evaluate electrical behavior and any changes thereof in both 
the cell membrane and cytosol.17–19
Figure 1 shows a typical dielectric spectra for erythrocytes 
dispersed in phosphate-buffered saline at 25°C. Permittivity 
(upper panel) and electrical conductivity (bottom panel) are 
shown separately, in the frequency range of 1 kHz to 2 gHz. 
The whole dielectric spectra, within the framework of effec-
tive medium theory approximation, can be described by a 
relaxation function as follows:
  εω ωϕ ϕϕ
β *( )( *, *, *, ) =+ +
− AF f effm peqw Φ   (1)
where ϕ* eff  and ϕ* m  represent the complex dielectric constant 
of the cell suspension and suspending medium, respectively, 
and ϕ* peq is the complex dielectric constant of the biological 
cell. The fractional volume of the cells in the suspension is 
denoted by Φ. The three terms of equation 1 correspond to 
the three different relaxation processes observed in biologi-
cal cell suspensions in this frequency range, ie, the electrode 
polarization effect (described by the function Aω-β), the 
interfacial polarization of heterogeneous systems (described 
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by the relaxation function, F), and the orientational relax-
ation in the aqueous phase (described by the relaxation 
   function, fw). The functional dependence of F on the electri-
cal parameters of the cell membrane, as demonstrated in the 
ellipsoidal single-shell model, is well known and has been 
reported in detail elsewhere.20,21
In this study, we focus our interest on dielectric dispersion 
(marked by a dotted circle in Figure 1) due to the interfacial 
polarization occurring because of accumulation of electri-
cal charge at the interface between the cell membrane and 
the extracellular medium. The other dielectric dispersions, 
ie, the dielectric dispersion in the low-frequency tail and 
the one in the high-frequency tail of the frequency window 
investigated are due to different polarization mechanisms that 
do not involve, at least at first approximation, the presence 
of the cell membrane. These two other dielectric disper-
sions are beyond the scope of the present paper and are not 
discussed further.
Statistical analysis
The results are presented as the mean ± standard deviation 
unless otherwise stated. Data within each group (the initial 
or later 4-month period) were analyzed by one-way analysis 
of variance followed by the Student-Newman-Keuls (SNK) 
test that makes pairwise comparison of groups after one-
way analysis of variance has rejected the null hypothesis. 
The analysis has been performed at a significance level of 
α = 0.01, whereby the hypothesis of equality of the means 
is rejected when one-way analysis of variance produces a 
P value less than α.
Results and discussion
The dielectric dispersion considered here contains the 
pertinent information by which it is possible to extract the 
electrical parameters relevant to the electrical characteriza-
tion of the cell membrane. They are membrane permittivity 
(εs) and membrane conductivity (σs), which represent the sign 
for possible alterations induced by the presence of the stent. 
Moreover, conductivity (σp) of the cytosol can be obtained 
as well. We have omitted many of the details of the technical 
procedures used and the fitting algorithm that allows us to 
do this. Details of this are reported extensively elsewhere.5,9 
Briefly, we employed the Levenberg-Marquardt algorithm15 
for complex functions which allows the simultaneous fit of 
real and imaginary parts of the complex dielectric constant 
with the same set of free parameters. Adopting this standard 
methodology,5,9 once the data were corrected for the electrode 
polarization effect, we derived the characteristic electrical 
parameters associated with the erythrocyte membrane, ie, 
membrane permittivity (εs), membrane conductivity (σs), 
and conductivity of the intracellular medium (σp, in the 
cytosol) for each of the samples investigated. These values 
were determined for each patient immediately before and 
after (within a period of time of 4 months and 8 months, 
respectively) insertion of the stent. These data are shown in 
Figures 2–4, reported as the difference between the values 
after and before treatment and normalized to the value before 
treatment.
As can be seen, all three parameters, referring to the entire 
sample investigated, showed marked alterations, in the sense 
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Figure 1 Typical dielectric spectra of erythrocytes in phosphate-buffered saline 
(hematocrit Φ 0.20) at a temperature of 25°C. 
Notes: Upper panel shows permittivity ε(ω) and bottom panel shows electrical 
conductivity σ(ω). The dotted circle marks the relaxation region associated with the 
interfacial polarization due to the ion distribution at the cell membrane interface. 
From this relaxation region, the parameters εs and σs, associated with the electrical 
characteristics of the cell membrane can be properly extracted. Full lines represent 
values calculated on the basis of the dielectric model used.
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that we recorded a marked increase in these parameters after 
stent implantation. In the absence of any interaction, we 
could record values close to zero, marked by a horizontal 
line in Figures 2–4. In these figures, we found a remark-
able scattering of the data. Given that we are reporting the 
normalized percentage change for each patient, the intrinsic 
variability of these parameters ascertainable in normal condi-
tions in healthy people should be at least in part accounted 
for. In spite of this, our data show that, compared with initial 
measurements, insertion of the stent provokes a substantial 
increase in their values in all patients investigated, with the 
exception of one. The results were investigated by one-way 
analysis of variance to test for differences before and after 
stent insertion. At P , 0.01, one-way analysis of variance 
showed that significant differences occurred between the 
groups. The second aspect we wanted to address was whether 
or not these alterations persist in time or if some type of 
recovery could take place. This issue has been considered in a 
previous paper,10,12 in which we reported measurements taken 
8 days and one month after stent insertion. In that case, we 
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Figure 2 Change in membrane permittivity εs normalized to the untreated value: [] εεε
s
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− /  of the erythrocyte membrane in different patients who underwent carotid 
artery stenting. 
Note: Absence of any alteration is indicated by the horizontal line.
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Figure 3 Change in membrane conductivity σs normalized to the untreated value: [] σσ σ
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− /  of the erythrocyte membrane in patients treated for carotid artery 
stenting. 
Note: Absence of any alteration is indicated by the horizontal line.
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artery stenting. 
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Figure 5 Changes in electrical parameters of the erythrocyte membrane occurring in the first 4 months from stent insertion (full symbols) and in the subsequent 4 months 
(open symbols). (A) Permittivity changes of intracellular medium (cytosol), (B) membrane conductivity changes, and (C) membrane permittivity changes.
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concluded, on the basis of an analysis of variance followed by 
a SNK test, that no difference occurred between 8 days and 
30 days of treatment. In the present experiment, we extended 
the temporal interval to 8 months, by dividing the patients 
into two groups, the first one with n = 8 considered within the 
first 4 months after stent insertion and the second one with 
n = 6 considered from months 4 to 8. Changes in the electri-
cal parameters, ie, membrane permittivity (εs), membrane 
conductivity (σs), and conductivity of the cytosol (σp), are 
shown in Figure 5. Analysis of variance showed a significant 
difference between the groups (P , 0.01), and the SNK test 
showed significant differences (P , 0.01) between controls 
and the first 4 months of treatment and between controls and 
the second 4 months of treatment, while no difference was 
found between the two groups for the first 4 months and the 
subsequent 4 months of treatment. This means that these 
alterations persist over a long period of time, and for at least 
8 months from stent insertion.
The reliability of the differences observed in the electrical 
parameters of the erythrocyte membrane based on the fitting 
algorithm we performed was checked further, considering 
the influence of electrical conductivity of the extracellular 
medium on estimates of the fitting parameters. Moreover, 
we measured, by means of optical microscopy, the size 
of the erythrocytes and their concentration in suspension 
using a Coulter cell analyzer. This information contributes 
to improve the quality of the fitting procedure, which is 
ultimately reflected in increased reliability of the electrical 
parameters of the cell membrane.
No pharmacological treatment was considered neces-
sary for the patients after stent insertion and in particular 
no antiplatelet drugs were administered. Consequently, the 
observed alterations cannot be attributed to drug consump-
tion. However, many factors could contribute to justify the 
observed alterations in electrical parameters. In particular, 
the increase in membrane conductivity (σs) is reflected in a 
decreased surface charge density at the outer cell membrane 
interface (surface density is about -3 µC/m2 in normal 
erythrocytes),22 playing a significant role in affecting the 
flow behavior of erythrocytes in the circulation. Because 
of the re-endothelialization process, we expected, at least 
in principle, that erythrocyte membrane-prosthesis interac-
tions should decrease as a function of time. On the contrary, 
the effects we observed persisted for at least 8 months after 
implantation.
Finally, as pointed out by Barbucci et al23 psychological 
stress may play a role in patients requiring a cardiovascu-
lar prosthesis, in which case any alterations would not be 
due to a direct effect of stent insertion. In any case, these 
  alterations might compromise the effective biocompatibility 
of the stent.
Conclusion
The principal aim of this research was to focus attention 
on use of a dielectric relaxation spectroscopy technique in 
characterization of the passive electrical properties of bio-
logical cell membranes when they are in close contact with 
artificial devices. By means of this technique, the membrane 
permittivity (εs) and membrane conductivity (σs) of the cell 
membrane can be properly evaluated, providing informa-
tion on both the structural and functional behavior of the 
membrane itself. Any alteration induced by the environment, 
with which the cell is in close contact, can be measured, and 
these parameters, in the event that they remain unaltered, 
can be considered as an index of the biocompatibility of the 
biomaterial used.
We evaluated possible alterations induced by stents used 
in the correction of carotid artery stenosis and observed 
that statistically significant differences occurred in passive 
electrical parameters of the erythrocyte membrane. These 
alterations suggest that full biocompatibility has not yet been 
reached. Despite the positive long-term results of metallic 
stents, further efforts must be directed towards achievement 
of ideal biocompatibility of stent materials, ie, an inert mate-
rial without chemical reactions involving human cells. Our 
results suggest that some caution is needed. In view of the 
current paucity of information on the basic mechanisms of 
interactions of stents with biological cells at a microscopic 
level, this approach, based on the characterization of the 
electrical properties of the plasma membrane by means of 
radiowave dielectric spectroscopy, opens up new possibili-
ties for improving the biocompatibility of biomaterials in 
biological applications.
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